Company Description
Streamex Corp., a medical device technology company, provides advanced digital signal processing solutions for electrophysiology in the United States.
The company offers the PURE EP platform, which delivers cardiac signal data to electrophysiologists during ablation procedures for the treatment of cardiovascular arrhythmias.
It also develops and operates the Streamex Exchange platform, a blockchain-based platform that facilitates the tokenization and exchange of real-world assets for the tokenized gold market.
In addition, the company offers software support, maintenance, and upgrade services. The company was formerly known as BioSig Technologies, Inc. and changed its name to Streamex Corp. in September 2025.
Streamex Corp. was incorporated in 2009 and is headquartered in Winter Park, Florida.
| Country | United States |
| Founded | 2009 |
| Industry | Capital Markets |
| Sector | Financials |
| Employees | 6 |
| CEO | Karl McPhie |
Contact Details
Address: 2431 Aloma Avenue, Suite 243 Winter Park, Florida 32792 United States | |
| Phone | 203 409 5444 |
| Website | streamex.com |
Stock Details
| Ticker Symbol | STEX |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1530766 |
| CUSIP Number | 09073N300 |
| ISIN Number | US09073N3008 |
| Employer ID | 26-4333375 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Karl Henry McPhie | Co-Founder, Chief Executive Officer and Director |
| Morgan Lekstrom | Co-Founder and Interim Executive Chairman |
| Mitchell Williams CFA | Chief Investment Officer |
| Christine M. Plummer | Chief Financial Officer and Principal Accounting and Financial Officer |
| Lora Mikolaitis | Chief Administrative Officer |
| Michael Frisch | General Counsel |
| Andrew Moskowitz | Head of BD and Partnerships |
| Tai Long Singh | Head of Product |
| Damion Simpkins | Head of Engineering |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 14, 2026 | 10-Q | Quarterly Report |
| May 4, 2026 | 8-K | Current Report |
| Apr 10, 2026 | 8-K | Current Report |
| Mar 31, 2026 | 10-K | Annual Report |
| Mar 27, 2026 | 8-K | Current Report |
| Mar 20, 2026 | 8-K | Current Report |
| Mar 6, 2026 | 8-K | Current Report |
| Feb 13, 2026 | 8-K | Current Report |
| Feb 13, 2026 | 424B5 | Filing |
| Feb 13, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |